Department of Epidemiology and Preventive Medicine, Regensburg University Medical Center, Regensburg, Germany.
Cancer Epidemiol Biomarkers Prev. 2013 Aug;22(8):1383-94. doi: 10.1158/1055-9965.EPI-13-0353. Epub 2013 May 29.
Increased body mass index (BMI) is an established colorectal cancer risk factor. High waist circumference or waist-hip-ratio (WHR) may better reflect an abnormal metabolic state and be more predictive of colorectal cancer risk than BMI.
We examined BMI, waist circumference, WHR, and hip circumference in relation to colorectal cancer risk among 203,177 participants followed for 10 years. We derived standardized colorectal cancer risk estimates for each anthropometric parameter and compared predictive characteristics (Harrell's C-index). In women, we examined whether hormone replacement therapy (HRT) use modified the associations between anthropometric measures and colorectal cancer.
We ascertained 2,869 colorectal cancers. In men, increased colon cancer risks were associated with BMI [HR per SD, 1.14; 95% confidence interval (CI), 1.08-1.20], waist circumference (HR per SD, 1.17; 95% CI, 1.08-1.27), and WHR (HR per SD, 1.09; 95% CI, 1.04-1.14). In women, anthropometric variables were unrelated to colon cancer. For men and women, anthropometric variables were unrelated to rectal cancer. Compared with BMI, waist circumference and WHR did not materially influence colon cancer prediction models [C-index changes: -0.0041 and 0.0046 (men); 0.0004 and 0.0005 (women)]. In current HRT users, colon cancer was inversely or suggestively inversely associated with waist circumference (HR per SD, 0.78; 95% CI, 0.63-0.97) and WHR (HR per SD, 0.88; 95% CI, 0.76-1.01), but positively related to hip circumference (HR per SD, 1.39; 95% CI, 1.13-1.71).
BMI, waist circumference, and WHR show comparable positive associations with colon cancer in men. Associations between anthropometric measures and colon cancer are weak or null in women, but there is some evidence for effect modification by HRT.
These findings may improve our understanding of the relation of adiposity to colorectal cancer.
体重指数(BMI)增加是结直肠癌的既定危险因素。腰围或腰臀比(WHR)较高可能更能反映代谢异常状态,并且比 BMI 更能预测结直肠癌的风险。
我们研究了 203177 名参与者 10 年的 BMI、腰围、WHR 和臀围与结直肠癌风险的关系。我们为每个人体测量参数得出了标准化的结直肠癌风险估计,并比较了预测特征(哈雷尔 C 指数)。在女性中,我们研究了激素替代疗法(HRT)的使用是否改变了人体测量指标与结直肠癌之间的关联。
我们确定了 2869 例结直肠癌。在男性中,结肠癌风险的增加与 BMI[每标准差 HR,1.14;95%置信区间(CI),1.08-1.20]、腰围(每标准差 HR,1.17;95%CI,1.08-1.27)和 WHR(每标准差 HR,1.09;95%CI,1.04-1.14)有关。在女性中,人体测量变量与结肠癌无关。对于男性和女性,人体测量变量与直肠癌无关。与 BMI 相比,腰围和 WHR 对结肠癌预测模型的影响不大[指数变化:男性为-0.0041 和 0.0046;女性为 0.0004 和 0.0005]。在当前使用 HRT 的患者中,腰围(每标准差 HR,0.78;95%CI,0.63-0.97)和 WHR(每标准差 HR,0.88;95%CI,0.76-1.01)与结肠癌呈负相关或提示性负相关,但与臀围(每标准差 HR,1.39;95%CI,1.13-1.71)呈正相关。
BMI、腰围和 WHR 与男性结肠癌呈正相关。在女性中,人体测量指标与结肠癌的关联较弱或为零,但 HRT 的作用存在一定的修饰作用。
这些发现可能有助于我们更好地了解肥胖与结直肠癌的关系。